Reticular

Y Combinator–backed company focused on scaling genomic AI for embryo selection and IVF risk reporting, offering at-home partner screening and reanalysis of existing PGT-A embryo data.

VisitClaim or join

Founded: Not disclosed
Headquarters: Not disclosed
Company size: 1–10
Products tracked: 2

Products by Reticular

2 products

Reticular Embryo AnalysisReanalyzes existing PGT-A embryo data across all embryos and all cycles for a flat fee, screening 500+ pregnancy-loss genes and reporting lifelong health risk across 24+ conditi...0.00 reviewsDrug Discovery & Biotech

Infertility & Pregnancy Loss PanelAt-home saliva screening kit that screens 750+ reproductive genes tied to infertility and recurrent pregnancy loss.0.00 reviewsDrug Discovery & Biotech

Pricing for Reticular

One Time

This is the broad commercial model reported for Reticular. Product-level terms are listed below when available.

Pricing model: One Time
Starting price: $1,000 flat fee · all embryos, all cycles; no per-embryo pricing; 100% refundable until analysis begins

Infertility & Pregnancy Loss PanelAt-home saliva screening kit that screens 750+ reproductive genes tied to infertility and recurrent pregnancy loss.

Pricing model: One Time
Starting price: $250 one partner / $500 both partners one-time; Affirm monthly installments from $23/mo (one partner) or $46/mo (both partners); HSA/FSA eligible; free shipping

Trust profile

Security and compliance

No compliance claims have been published for this company.

encryption_at_rest

encryption_in_transit